Sarah Westen
Clinical Assistant Professor | Director University of Florida
- Gainesville FL
Sarah Westen's patient-oriented clinical research focuses on biopsychosocial factors related to health engagement.
Biography
Areas of Expertise
Media Appearances
Sarah Westen, PhD invited to speak at the American Diabetes Association’s (ADA) 2024 Clinical Update Conference
UF Department of Clinical and Health Psychology online
2024-01-08
Congratulations to CHP’s Sarah Westen, Ph.D., on her invitation to speak at the American Diabetes Association’s (ADA) 2024 Clinical Update Conference on February 2-4 in Orlando, Florida. Leaders in diabetes care from around the world will attend. Dr. Westen will speak on the implementation of the ADA’s newly released 2024 Standards of Care in Diabetes and showcase a video project (linked below) on strategies to improve patient-centered care in the clinic setting.
Social
Articles
Language evolves - so can you
Nature Reviews EndocrinologyWesten & Jacobsen
2025-10-21
As healthcare professionals, scientists and educators, our intent is to empower people affected by diabetes mellitus; however, if our language is stigmatizing, our impact might be disempowerment. If we do not choose our words with care, we risk undermining the very autonomy we seek to promote.
Project ECHO Diabetes Trial Improves Outcomes for Medically Underserved People
Diabetes CareWalker, et al.
2024-12-17
The Project Extension for Community Healthcare Outcomes (ECHO) model is used in 180 countries to address chronic disease care through a provider empowerment, tele-education approach. Few studies have rigorously evaluated the impact of the program on patient outcomes using randomized designs.
Objectively Measured Adherence in Adolescents With Type 1 Diabetes on Multiple Daily Injections and Insulin Pump Therapy
Journal of Pediatric PsychologyWestern, et al.
2019-01-01
Type 1 diabetes poses unique challenges to adherence-related behavior because of complex treatment regimens that vary by use of specific technologies. This study used objective data to determine prevalence rates of adherence behaviors in adolescents with T1D and relationships between adherence and glycemic control.


